Last reviewed · How we verify

NCT05320003

Assessment of Balance in Patients With Pes Planus

Status unknown NA Last updated 11 April 2022
What this trial tests

NA trial testing Inky foot analysis in Pes Planus in 40 participants. Status unknown.

Timeline
6 April 2022
Primary endpoint
15 April 2022
15 May 2022

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment40
Start date6 April 2022
Primary completion15 April 2022
Estimated completion15 May 2022

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 50 to 65, any sex, with Pes Planus or Fall Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Pes planus is a foot deformity with increased contact of the foot with the ground as a result of the decrease or disappearance of the medial longitudinal arch of the foot. The arch of the foot creates an adaptive and flexible support for the whole body, and biomechanical changes in the foot can affect the whole body posture and balance. The results of the studies evaluating balance and plantar pressure analysis in adults with pes planus seem contradictory. The aim of this study is to evaluate fall risk and plantar pressure in adults with pes planus aged 50 -65 years

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pes Planus

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05320003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing